scorecardresearch
Add as a preferred source on Google
Thursday, April 9, 2026
TopicObesity

Topic: Obesity

Why do weight loss drugs work for some and not for others? New study finds

A study, published in Nature, investigated drugs such as semaglutide and tirzepatide, which have gained global attention for their effectiveness in reducing body weight.

FSSAI has failed to resolve diet-related issues in India—public health crisis on the rise

The key question before us is simple: Whose interest should guide food policy in India? The credibility of India's food regulatory system depends on the answer to this question.

A 5-spice mix to fight long-term diabetes & obesity complications? ICMR set to back human trials

Looking beyond blood sugar control, ICMR-NIN scientists have combined 5 regular kitchen spices in precise proportions, 'marking a shift toward integrative health solutions'.

FSSAI seeks more time from SC to work on front-of-pack labels for foods with high fat, sugar & salt

Food regulator FSSAI weighs pictures versus labels on packaged food amid growing pressure for long-overdue health reform.

India braces for cheaper anti-obesity drugs as Ozempic patent expires

With semaglutide patent ending, Indian pharma firms are set to launch lower-cost versions, prompting hospitals and clinics to expand obesity services ahead of a surge in demand.

As semaglutide goes off patent, weight-loss gold rush begins. Pharma bets big, court case lingers

Several leading Indian drugmakers have already secured regulatory approval or recommendations to produce and market generic versions of the weight loss drugs in India.

3 popular GLP-1 drugs may work on rare & hard-to-treat genetic obesity, Japanese researchers find

Children with certain genetic defects affecting hunger control can become severely obese from the age of one or two. Findings suggest that medicines based on GLP-1 hormone may work.

Supriya Pathak and Ratna Pathak Shah tackle obesity stigma in new ad. ‘It’s not a joke’

The ad by Lilly India is opening the door to a weight loss conversation. It features links to research papers from the World Health Organisation and Columbia University.

Lancet study links obesity to 1 in 10 infection deaths globally. What it means for India

Study analysed data from over 540,000 adults in Finland and the UK. To study worldwide estimates, the researchers then used global data from the Global Burden of Diseases (GBD) Study.

What are China’s ‘fat prisons’? The country’s unusual way of dealing with obesity

These facilities have locked gates and perimeter fencing with huge walls on all sides, and no participant can willingly leave during the course unless they have a valid reason.

On Camera

A stronger Iran has emerged from the rubble. US learned the lesson 40 days late

The US and Israel’s assassinations of Iranian leadership ended up bestowing martyrdom on those killed. Shias saw the deaths as a continuity of martyrdom from the Battle of Karbala.

Data centre gold rush risks blackouts, central electricity body warns states against tripping grids

India’s fast-growing data centre sector may strain state electricity networks; Central Electricity Authority has urged Maharashtra, Andhra Pradesh, Telangana and Tamil Nadu to boost capacity.

Too early to draw lessons from US-Israel & Iran war, India monitoring like a hawk—Navy chief

Indian Navy chief Admiral Dinesh Tripathi said that the ongoing conflict in West Asia illustrates that speed is no longer merely an enabler of warfare but a distinct capability.

China insulated itself against energy shocks. India is ‘all talk, no walk’

China patiently invested capital, skill and technology in coal gasification. Unlike it, we won’t move from words to action. As crude prices decline, we lose interest.